April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Three-Year Follow-Up of Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Diffuse Diabetic Macular Edema
Author Affiliations & Notes
  • Y. Kim
    Department of Ophthalmology, Samsung Medical Center, Seoul, Republic of Korea
  • S. Kang
    Department of Ophthalmology, Samsung Medical Center, Seoul, Republic of Korea
  • C.-H. Yi
    Department of Ophthalmology, Samsung Medical Center, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  Y. Kim, None; S. Kang, None; C.-H. Yi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4260. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Kim, S. Kang, C.-H. Yi; Three-Year Follow-Up of Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Diffuse Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4260.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report 3-year outcomes of macular laser photocoagulation following intravitreal injection of 4 mg of triamcinolone acetonide (IVTA) for diffuse diabetic macular edema (DME).

Methods: : Eighty-six eyes of 75 patients with diffuse DME were randomized into 2 groups. The eyes assigned to the combination group (n=48) were subjected to macular laser photocoagulation 3 weeks after IVTA. The eyes in the IVTA group (n=38) underwent IVTA alone. Central macular thickness (as measured by optical coherence tomography), the number of additional treatments, and the mean time to recurrence of DME were evaluated.

Results: : Thirty-seven eyes in the combination group and 26 eyes in the IVTA group completed the 3-year follow-up. Nine of 37 eyes (24.32%) in the combination group and 1 eye of 26 (3.85%) in IVTA group showed no recurrence of DME after initial treatment (P=0.028). Macular edema was not present for 19.88 months in the combination group after treatment compared to 10.33 months in the IVTA group (P = 0.027). The mean number of additional treatments was 0.92 in the combination group and 1.88 in the IVTA group (P = 0.001).

Conclusions: : The results in the subset of subjects who completed the 3-year follow-up demonstrated that combination therapy is more effective for diffuse DME than IVTA monotherapy. Combination therapy required fewer additional treatments and showed a lower recurrence rate than IVTA monotherapy.

Keywords: diabetic retinopathy • edema • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×